AKT1 and cancer: Concurrent KEGG analysis supported the significant downregulation of pathways associated with ECM-receptor interactions, focal adhesions, PI3K-Akt signaling, proteoglycans in cancer, and IL-17 signaling post-FAP ablation (Figure 4(f)).